C

China Meheco Group Co Ltd
SSE:600056

Watchlist Manager
China Meheco Group Co Ltd
SSE:600056
Watchlist
Price: 10.88 CNY -0.73% Market Closed
Market Cap: ¥16.3B

Operating Margin

2.7%
Current
Declining
by 0.5%
vs 3-y average of 3.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
2.7%
=
Operating Income
¥923.2m
/
Revenue
¥33.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
2.7%
=
Operating Income
¥923.2m
/
Revenue
¥33.9B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
China Meheco Group Co Ltd
SSE:600056
16.4B CNY
Loading...
JP
Mitsubishi Corp
TSE:8058
15.4T JPY
Loading...
JP
Itochu Corp
TSE:8001
15.3T JPY
Loading...
JP
Mitsui & Co Ltd
TSE:8031
14.3T JPY
Loading...
US
United Rentals Inc
NYSE:URI
57.9B USD
Loading...
JP
Marubeni Corp
TSE:8002
8.3T JPY
Loading...
US
WW Grainger Inc
XMUN:GWW
42.4B EUR
Loading...
US
Fastenal Co
NASDAQ:FAST
50.1B USD
Loading...
US
W W Grainger Inc
NYSE:GWW
50.7B USD
Loading...
US
Ferguson Enterprises Inc
NYSE:FERG
49.3B USD
Loading...
JP
Sumitomo Corp
TSE:8053
7.5T JPY
Loading...

Market Distribution

In line with most companies in China
Percentile
44rd
Based on 8 544 companies
44rd percentile
2.7%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

China Meheco Group Co Ltd
Glance View

China Meheco Group Co., Ltd., established in 1984, stands as a prominent player in the Chinese pharmaceutical and healthcare sector. As the company evolved over the decades, it navigated the complex Chinese market by strategically positioning itself across the entire pharmaceutical value chain. This involved investing heavily in research and development, securing partnerships with both domestic and international pharmaceutical companies, and streamlining its distribution network to enhance efficiency. Such endeavors have enabled China Meheco to develop and distribute a wide range of medical products, including active pharmaceutical ingredients, finished drugs, medical devices, and traditional Chinese medicines. The company leverages its robust R&D capabilities to continually bring innovative products to market, which has been a significant source of its revenue. China Meheco's business model thrives on its expansive distribution network and strategic collaborations. By aligning with global pharmaceutical giants, the company not only gains access to cutting-edge technologies and advanced formulations but also expands its market reach beyond China. This dual strategy of innovation and partnership ensures a steady flow of products that cater to diverse healthcare needs. Furthermore, China Meheco capitalizes on its local expertise and deep understanding of regulatory frameworks, allowing it to maneuver efficiently within China's complex healthcare landscape. This approach underpins its ability to capture substantial market share in a competitive industry, driving profitability and positioning the company as a key player in the global pharmaceutical arena.

Intrinsic Value
15.06 CNY
Undervaluation 28%
Intrinsic Value
Price
C
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
2.7%
=
Operating Income
¥923.2m
/
Revenue
¥33.9B
What is China Meheco Group Co Ltd's current Operating Margin?

The current Operating Margin for China Meheco Group Co Ltd is 2.7%, which is below its 3-year median of 3.2%.

How has Operating Margin changed over time?

Over the last 3 years, China Meheco Group Co Ltd’s Operating Margin has decreased from 2.9% to 2.7%. During this period, it reached a low of 2.6% on Jun 30, 2025 and a high of 3.7% on Dec 31, 2022.

Back to Top